Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 1
2016 1
2018 4
2019 1
2020 4
2021 5
2022 4
2023 9
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
[Asymptomatic choroidal tuberculoma].
Dambricourt L, Vie AL, Ojeda M, Meziani L, Oudart F. Dambricourt L, et al. Among authors: meziani l. J Fr Ophtalmol. 2021 Mar;44(3):469-471. doi: 10.1016/j.jfo.2020.04.044. Epub 2020 Nov 16. J Fr Ophtalmol. 2021. PMID: 33213940 French. No abstract available.
COVID-19-Associated Pneumonia: Radiobiological Insights.
François S, Helissey C, Cavallero S, Drouet M, Libert N, Cosset JM, Deutsch E, Meziani L, Chargari C. François S, et al. Among authors: meziani l. Front Pharmacol. 2021 May 25;12:640040. doi: 10.3389/fphar.2021.640040. eCollection 2021. Front Pharmacol. 2021. PMID: 34113249 Free PMC article. Review.
[Radiation-induced pulmonary fibrosis: New potential targets].
Deutsch E, Meziani L. Deutsch E, et al. Among authors: meziani l. Cancer Radiother. 2023 Sep;27(6-7):491-493. doi: 10.1016/j.canrad.2023.06.026. Epub 2023 Aug 16. Cancer Radiother. 2023. PMID: 37596124 Review. French.
Radio-induced lymphopenia in the era of anti-cancer immunotherapy.
de Kermenguy F, Meziani L, Mondini M, Clémenson C, Morel D, Deutsch E, Robert C. de Kermenguy F, et al. Among authors: meziani l. Int Rev Cell Mol Biol. 2023;378:1-30. doi: 10.1016/bs.ircmb.2023.03.002. Epub 2023 Apr 3. Int Rev Cell Mol Biol. 2023. PMID: 37438014 Review.
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer.
Levy A, Morel D, Texier M, Sun R, Durand-Labrunie J, Rodriguez-Ruiz ME, Racadot S, Supiot S, Magné N, Cyrille S, Louvel G, Massard C, Verlingue L, Bouquet F, Bustillos A, Bouarroudj L, Quevrin C, Clémenson C, Mondini M, Meziani L, Tselikas L, Bahleda R, Hollebecque A, Deutsch E. Levy A, et al. Among authors: meziani l. Mol Cancer. 2024 Mar 23;23(1):61. doi: 10.1186/s12943-024-01970-8. Mol Cancer. 2024. PMID: 38519913 Free PMC article. Clinical Trial.
Non-homogenous intratumor ionizing radiation doses synergize with PD1 and CXCR2 blockade.
Bergeron P, Dos Santos M, Sitterle L, Tarlet G, Lavigne J, Liu W, Gerbé de Thoré M, Clémenson C, Meziani L, Schott C, Mazzaschi G, Berthelot K, Benadjaoud MA, Milliat F, Deutsch E, Mondini M. Bergeron P, et al. Among authors: meziani l. Nat Commun. 2024 Oct 14;15(1):8845. doi: 10.1038/s41467-024-53015-9. Nat Commun. 2024. PMID: 39397001 Free PMC article.
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.
Chen J, Levy A, Tian AL, Huang X, Cai G, Fidelle M, Rauber C, Ly P, Pizzato E, Sitterle L, Piccinno G, Liu P, Durand S, Mao M, Zhao L, Iebba V, Felchle H, Mallard de La Varende AL, Fischer JC, Thomas S, Greten TF, Jones JC, Monge C, Demaria S, Formenti S, Belluomini L, Dionisi V, Massard C, Blanchard P, Robert C, Quevrin C, Lopes E, Clémenson C, Mondini M, Meziani L, Zhan Y, Zeng C, Cai Q, Morel D, Sun R, Laurent PA, Mangoni M, Di Cataldo V, Arilli C, Trommer M, Wegen S, Neppl S, Riechelmann RP, Camandaroba MP, Neto ES, Fournier PE, Segata N, Holicek P, Galluzzi L, Buqué A, Alves Costa Silva C, Derosa L, Kroemer G, Chen C, Zitvogel L, Deutsch E. Chen J, et al. Among authors: meziani l. Cancer Cell. 2025 Mar 10;43(3):361-379.e10. doi: 10.1016/j.ccell.2025.02.010. Cancer Cell. 2025. PMID: 40068595 Free article.
KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partner.
Laurent PA, Milic M, Quevrin C, Meziani L, Liu W, Morel D, Signolle N, Clémenson C, Levy A, Mondini M, Deutsch E. Laurent PA, et al. Among authors: meziani l. J Transl Med. 2023 Oct 31;21(1):773. doi: 10.1186/s12967-023-04619-0. J Transl Med. 2023. PMID: 37907934 Free PMC article.
Antitumor Effect by Either FLASH or Conventional Dose Rate Irradiation Involves Equivalent Immune Responses.
Almeida A, Godfroid C, Leavitt RJ, Montay-Gruel P, Petit B, Romero J, Ollivier J, Meziani L, Sprengers K, Paisley R, Grilj V, Limoli CL, Romero P, Vozenin MC. Almeida A, et al. Among authors: meziani l. Int J Radiat Oncol Biol Phys. 2024 Mar 15;118(4):1110-1122. doi: 10.1016/j.ijrobp.2023.10.031. Epub 2023 Nov 10. Int J Radiat Oncol Biol Phys. 2024. PMID: 37951550 Free PMC article.
33 results